
FDA Approves Updated Pfizer-BioNTech and Moderna COVID Vaccines for 2026-27 Season
The U.S. Food and Drug Administration has approved updated COVID-19 vaccines from Pfizer-BioNTech and Moderna, specifically formulated to target the XFG variant for the 2026-2027 season. The decision clears the way for domestic manufacturers to begin distributing the updated shots to healthcare providers.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (42/100)Sources
Pfizer, BioNTech win approval for updated COVID-19 shot
Read full article →US FDA approves updated COVID vaccines for 2026-27 season
By Reuters
Read full article →Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine - Taiwan News
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine Taiwan News
Read full article →Coverage Timeline
Related Stories
US FTC Launches Probe Into YouTube’s Social Media Policies
23m ago

Golf Channel Cancels Show and Callaway Ends Partnership Following Good Good Backlash
30m ago
United States Negotiates Major Stake in Venezuelan Oil Fields
36m ago

Universal Studios Japan Announces Multi-Billion Dollar Expansion Plan
40m ago